Karuna Therapeutics, Inc. (KRTX): Price and Financial Metrics

Karuna Therapeutics, Inc. (KRTX): $329.83

0.09 (+0.03%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add KRTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#314 of 342

in industry

KRTX Price/Volume Stats

Current price $329.83 52-week high $329.99
Prev. close $329.74 52-week low $158.38
Day low $329.75 Volume 1,868,500
Day high $329.99 Avg. volume 832,048
50-day MA $317.38 Dividend yield N/A
200-day MA $228.31 Market Cap 12.58B

KRTX Stock Price Chart Interactive Chart >


Karuna Therapeutics, Inc. (KRTX) Company Bio


Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company develops treatments for people afflicted with schizophrenia. Karuna Therapeutics was founded in July 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.


KRTX Latest News Stream


Event/Time News Detail
Loading, please wait...

KRTX Latest Social Stream


Loading social stream, please wait...

View Full KRTX Social Stream

KRTX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 60.52%
3-year 198.11%
5-year 412.00%
YTD 4.21%
2023 61.07%
2022 50.00%
2021 28.95%
2020 34.84%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!